Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 17.15 is 54% above its 5-year average of 11.14, around the middle of its 5-year range (0.12–35.74).
As of the fiscal period ended Tuesday, June 30, 2026. 2.53% above its 12-month average of 16.73.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 17.15.
QUICK RATIO (ACID-TEST)
17.15
QUICK RATIO (ACID-TEST) AVG TTM
16.73
QUICK RATIO (ACID-TEST) AVG 3Y
10.88
QUICK RATIO (ACID-TEST) AVG 5Y
11.14
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.53%
CURRENT VS 3Y AVG
+57.61%
CURRENT VS 5Y AVG
+53.93%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.79
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
+513.57%
vs the sector median at left
Cardio Diagnostics Holdings, Inc.
Market Cap
$6.10M
Quick Ratio (Acid-Test)
17.15
TTM Avg
16.73
3Y Avg
10.88
5Y Avg
11.14
Market Cap
$6.09M
Quick Ratio (Acid-Test)
119.39
TTM Avg
100.04
3Y Avg
53.35
5Y Avg
40.07
Market Cap
$6.03M
Quick Ratio (Acid-Test)
2.35
TTM Avg
1.31
3Y Avg
0.84
5Y Avg
0.78
Market Cap
$6.34M
Quick Ratio (Acid-Test)
0.93
TTM Avg
1.44
3Y Avg
2.71
5Y Avg
3.16
Market Cap
$6.44M
Quick Ratio (Acid-Test)
N/A
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.05
Market Cap
$5.63M
Quick Ratio (Acid-Test)
3.88
TTM Avg
2.19
3Y Avg
2.86
5Y Avg
5.66
Market Cap
$6.72M
Quick Ratio (Acid-Test)
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$6.74M
Quick Ratio (Acid-Test)
16.20
TTM Avg
7.76
3Y Avg
4.60
5Y Avg
3.08
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | $6.10M | 17.15 | 16.73 | 10.88 | 11.14 |
| Femasys Inc. (FEMY)vs › | $6.10M | 0.55 | 1.77 | 4.96 | 6.03 |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 119.39 | 100.04 | 53.35 | 40.07 |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | 2.35 | 1.31 | 0.84 | 0.78 |
| Biomerica, Inc. (BMRA)vs › | $6.34M | 0.93 | 1.44 | 2.71 | 3.16 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | N/A | 2.00 | 1.31 | 1.05 |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | 3.88 | 2.19 | 2.86 | 5.66 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | 2.61 | 3.40 | 4.86 | 5.09 |
| Aclarion, Inc. (ACON)vs › | $6.74M | 16.20 | 7.76 | 4.60 | 3.08 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 10.21 | 3.61 | 3.34 | 4.20 |
Quick Ratio
17.15
Excludes inventory
Current Ratio
17.15
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 17.15 |
| 2026-03-31 | 15.76 |
| 2025-12-31 | 9.79 |
| 2025-09-30 | 17.39 |
| 2025-06-30 | 23.55 |
| 2025-03-31 | 19.49 |
| 2024-12-31 | 13.92 |
| 2024-09-30 | 8.51 |
| 2024-06-30 | 5.69 |
| 2024-03-31 | 3.78 |
| 2023-12-31 | 3.29 |
| 2023-09-30 | 1.53 |
| 2023-06-30 | 1.63 |
| 2023-03-31 | 1.59 |
| 2022-12-31 | 3.02 |
| 2022-09-30 | 35.74 |
| 2022-06-30 | 18.42 |
| 2022-03-31 | 9.48 |
| 2021-12-31 | 23.71 |
| 2021-09-30 | 0.12 |
| 2021-06-30 | 0.43 |
| 2021-03-31 | 0.00 |
